Life Science Editors (LSE) embeds PhD scientists and former top journal editors directly into your communications workflow to advance programs without compromising scientific integrity.
LSE transforms rigorous research into partner-ready pitch decks, fundable grant applications, high-impact publications, pitch deck and data room optimization, and scientific figures.
With a track record spanning top-10 pharma, leading and start-up biotech, and 25+ academic medical centers worldwide, LSE accelerating the work between your data and its impact without diluting your scientific voice.
Life Science Editors is committed to delivering rigorous, thoughtful, and efficient support helping clients communicate their science with clarity, precision, and impact, without losing the scientific voice along the way.
LSE transforms rigorous research into partner-ready pitch decks, fundable grant applications, high-impact publications, pitch deck and data room optimization, and scientific figures.
With a track record spanning top-10 pharma, leading and start-up biotech, and 25+ academic medical centers worldwide, LSE accelerating the work between your data and its impact without diluting your scientific voice.
Life Science Editors is committed to delivering rigorous, thoughtful, and efficient support helping clients communicate their science with clarity, precision, and impact, without losing the scientific voice along the way.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. . The new name reflects the charity’s purpose: to be the arc or bridge between research and improving patients’ lives.. . LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. . . So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance. . . https://www.lifearc.org Twitter @lifearc1.
LifeSciences BC is a not-for-profit, non-government industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and advocacy and promotion of our world-class science and industry. Life science sectors, from biopharmaceuticals and medical technology to digital health and medical devices, are integrated into our organisation and our activities, ensuring that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary and coordinated fashion. Throughout the year, LifeSciences BC undertakes numerous programmes and projects in support of these sectors.
LimestoneGrey is a specialist R&D tax credit consultancy, working closely with life sciences, med-tech, and biotech companies across the UK, building strong relationships and providing a personal, tailored approach to navigating R&D tax relief.
Watch our Member Showcase Video https://bit.ly/3nDy86q
No data available
No data available
Macomics is an immuno-oncology company with world-leading expertise in macrophage biology. We are focused on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defense against tumors.
Mandeville Technology Limited provides flexible chief financial officer or finance director services to healthcare and technology companies. Services in the following areas are available: accounting, including audit preparation, financial reporting and management accounts; company secretarial; corporate finance, including deal structuring, disposals, equity funding, financial modelling, mergers and acquisitions, valuations and venture debt; corporate and financial strategy, including budgeting and forecasting, business and financial advice and corporate restructuring; employee incentive schemes, including EMI share options, employee benefit trusts and share purchase schemes; non-executive director; and taxation, including: EIS, R&D tax credits and VAT.
No data available